Raymond James & Associates’s Celestica CLS Stock Holding History

Raymond James & Associates’s Portfolio CLS Stock Details CLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$3.58M	Sell	70,073 -38,857	-36%	-$2.01M	﹤0.01%	1872
2024 Q2	$6.24M	Buy	108,930 +48,323	+80%	+$2.44M	﹤0.01%	1432
2024 Q1	$2.72M	Buy	60,607 +12,850	+27%	+$488K	﹤0.01%	1972
2023 Q4	$1.4M	Buy	47,757 +14,072	+42%	+$374K	﹤0.01%	2312
2023 Q3	$826K	Sell	33,685 -43,642	-56%	-$893K	﹤0.01%	2588
2023 Q2	$1.12M	Buy	+77,327	New	+$957K	﹤0.01%	2399
2022 Q2	–	Sell	-11,122	Closed	-$132K	–	4051
2022 Q1	$132K	Buy	+11,122	New	+$131K	﹤0.01%	3770

Other funds holding CLS

WRCM

Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Raymond James & Associates's CLS Position: Q3 2024 in Review

Raymond James & Associates reduced its Celestica (CLS) stake by 36% in Q3 2024, selling an estimated $2.01M and leaving 70,073 shares worth $3.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1872.

Raymond James & Associates first reported a position in CLS in Q1 2022 and has held it in 7 quarters since. The position peaked at $6.24M in Q2 2024. 354 funds tracked by Wall St. Rank hold CLS as of Q3 2024.

Raymond James & Associates held 70,073 shares of Celestica worth $3.58M as of Q3 2024.
Raymond James & Associates sold 38,857 Celestica shares in Q3 2024, an estimated $2.01M.
Celestica made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1872 holding.
Raymond James & Associates first reported a position in Celestica in Q1 2022 and has held it in 7 quarters since.
Raymond James & Associates's Celestica position peaked at $6.24M in Q2 2024.
354 funds tracked by Wall St. Rank held Celestica as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.